Advertisement

Diarrheal Diseases and Probiotics

  • Yoko Yanagawa
  • Kazuo Tanaka

Abstract

Infectious diseases accounted for 56% of the total mortality of children under five years of age worldwide in 2004. Diarrheal diseases accounted for a relatively high 17% of these diseases, thus, becoming a serious problem. In fact, a great number of people have been infected by microorganisms, such as E.coli O157, Shigella sp., Salmonella sp., and Vibrio cholerae. In particular, rotavirus infects older infants and young children 4 months to 2 years of age; severe diarrheal infections account for 40% of these cases. Rotavirus found in both developing and developed countries is, therefore, the leading cause of viral intestinal infections. On the other hand, C. difficile has been implicated as a causative agent in antibiotic-associated diarrhea (AAD) and pseudomembranous colitis (PMC) in developed countries. With regard to diarrheal causative microorganisms, this report focuses principally on rotavirus, C.difficile and the efficiency of probiotics. Probiotics are foods that contain live bacteria, are sold as yogurt, pills and other fermented foods, and are beneficial to health. Probiotics given enterally are essentially a means of delivering active constituents such as enzymes or antimicrobial substances to targets in the gastrointestinal tract and are effective against rotaviral diarrhea in children under 5 years of age. In C.difficile antibiotic-induced diarrhea, after oral administration of S. boulardii, many studies have confirmed that probiotics result in a low incidence of AAD and shorten the duration of diarrhea. For other enteropathogenic bacteria, such as V. cholerae, Shigella sp., Salmonella sp., and Campylobacter sp., therapies using antibiotics and rehydration have been established although many kinds of microbial species have been used for probiotic treatment.

Keywords

Clostridium Difficile Methicillin Resistant Staphylococcus Aureus Diarrheal Disease Rotaviral Infection Pseudomembranous Colitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Boschi-Pinto C, Velebit L, Shibuya K (2008) Estimating child mortality due to diarrhea in developing countries. Bull World Health Organ. 86:710–717CrossRefPubMedGoogle Scholar
  2. 2.
    Brandtzaeg P, Halstensen TS, Kett K, Solid LM (1989) Immunobiology and Immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes. Gastroenterology 97: 1562–1584PubMedGoogle Scholar
  3. 3.
    Corthier G, Dubos F, Ducluzeau R (1986) Prevention of Clostridium difficile induced mortality in gnotobiotic mice by Saccharomyces boulardii. Can J Microbiol 32:894–896CrossRefPubMedGoogle Scholar
  4. 4.
    Fuller R (1989) Probiotics in man and animals. J Appl Bacteriol. 66:365–378.PubMedGoogle Scholar
  5. 5.
    Huang JS, Bousvaros A, Lee JW, Diaz A, Davidson EJ (2002) Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci 47:2625–2635CrossRefPubMedGoogle Scholar
  6. 6.
    Kamiya S (1993) Virulence factors of Clostridium difficile and its patho-genesis in intestinal infection in man. Bifidobacteria Microflora 12:1–7Google Scholar
  7. 7.
    Kamiya S (2003) Enteric infectious diseases and probiotics. Igakunoayumi (in Jananese) 207:894–898Google Scholar
  8. 8.
    Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, Bourgault AM, Nguyen T, Frenette C, Kelly M, Vibien A, Brassard P, Fenn S, Dewar K, Hudson TJ, Horn R, René P, Monczak Y, Dascal A (2005) A predominantly clonal multi-institutional outbreak of Clostridium difficile associated diarrhea with high morbidity and mortality. N Engl J Med 353: 2442–2449CrossRefPubMedGoogle Scholar
  9. 9.
    McDonald LC, Killgore GE, Thompson A, Owens RC Jr, Kazakova SV, Sambol SP, Johnson S, Gerding DN (2005) An epidemic, toxin-gene-variant strain of Clostridium difficile. N Engl J Med 353:2433–2441CrossRefPubMedGoogle Scholar
  10. 10.
    Marteau PR, de Vrese M, Cellier CJ, Schrezenmeir J (2001) Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr 73: s430–436Google Scholar
  11. 11.
    Morens DM, Folkers GK, Fauci AS (2004) The challenge of emerging and reemerging infectious diseases. Nature 8 430:242–249CrossRefGoogle Scholar
  12. 12.
    Nomoto K (2005) Prevention of infections by probiotics. J Biocsi Bioeng 6:583–592CrossRefGoogle Scholar
  13. 13.
    Ozaki E, Kato H, Kita H, Karasawa T, Maegawa T, Koino Y, Matsumoto K, Takada T, Nomoto K, Tanaka R, Nakamura S (2004) Clostridium difficile colonization in healthy adults: transient colonization and correlation with enterococcal colonization. J Med Microbiol. 53:167–172CrossRefPubMedGoogle Scholar
  14. 14.
    Salminen S, Bouley C, Boutron-Ruault MC, Cummings JH, Franck A, Gibson GR, Isolauri E, Moreau MC, Roberfroid M, Rowland I (1998) Functional food science and gastrointestinal physiology and function. Br J Nutr 80:s147–171CrossRefGoogle Scholar
  15. 15.
    Sneath PH, Mair NS, Sharpe ME, Holt JG (1984) Burgey’s Manual of Systematic Bacteriology. Volume 2. Baltimore: Williams and Wilkins. p1141–1200Google Scholar
  16. 16.
    Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, Frost E, McDonald LC (2005) Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366:1079–1084CrossRefPubMedGoogle Scholar
  17. 17.
    Winn WC, Allen SD, Janda WM, Koneman EW, Schreckenberger PC, Procop GW, Woods GL (2006) Koneman’s Color Atlas and Textbook of Diagnostic Microbiology. 6th ed. Philadelphia: Lippincott Williams and Willkins. p877–944Google Scholar
  18. 18.
    World Health Organization (2004) The World Health Report 2004: World Health Organization, GenevaGoogle Scholar
  19. 19.
    World Health Organization (2009) Repot of the Strategic Advisory Group of Experts (SAGE): World Health Organization, GenevaGoogle Scholar
  20. 20.
    World Health Organization (2007) The World Health Report 2007: World Health Organization, GenevaGoogle Scholar

Copyright information

© Springer 2010

Authors and Affiliations

  • Yoko Yanagawa
    • 1
  • Kazuo Tanaka
    • 1
  1. 1.Department of Microbiology and ImmunologyShowa University School of MedicineTokyoJapan

Personalised recommendations